Kamis, 30 November 2017

Sponsored Links

Pharma Sastra
src: 2.bp.blogspot.com

Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome however its use as a potential antipsychotic drug for the treatment of schizophrenia has been discontinued.


Video Talnetant



See also

  • Fezolinetant
  • MLE-4901
  • Osanetant

Maps Talnetant



References



Source of the article : Wikipedia

Comments
0 Comments